BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 25501114)

  • 21. [Detection of chromosomal translocations of DUSP22 and TP63 in ALK-negative anaplastic large cell lymphoma by fluorescence in situ hybridization and related clinical relevance].
    Wang C; Chen X; Chen XY; He YH
    Zhonghua Bing Li Xue Za Zhi; 2019 Oct; 48(10):791-795. PubMed ID: 31594044
    [No Abstract]   [Full Text] [Related]  

  • 22. Dual ALK and MYC rearrangements leading to an aggressive variant of anaplastic large cell lymphoma.
    Liang X; Branchford B; Greffe B; McGavran L; Carstens B; Meltesen L; Albano EA; Quinones R; Cook B; Graham DK
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):e209-13. PubMed ID: 23619105
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oncogenic role of miR-155 in anaplastic large cell lymphoma lacking the t(2;5) translocation.
    Merkel O; Hamacher F; Griessl R; Grabner L; Schiefer AI; Prutsch N; Baer C; Egger G; Schlederer M; Krenn PW; Hartmann TN; Simonitsch-Klupp I; Plass C; Staber PB; Moriggl R; Turner SD; Greil R; Kenner L
    J Pathol; 2015 Aug; 236(4):445-56. PubMed ID: 25820993
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Morphological and phenotypic features in pediatric large cell lymphoma and their correlation with ALK expression and the t(2;5)(p23;q35) translocation.
    Sherman CG; Zielenska M; Lorenzana AN; Pulford KA; Mason DY; Hutchison RE; Thorner PS
    Pediatr Dev Pathol; 2001; 4(2):129-37. PubMed ID: 11178628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of a TRAF1-ALK fusion in an anaplastic large cell lymphoma patient with chemotherapy and ALK inhibitor-resistant disease.
    Lawrence K; Berry B; Handshoe J; Hout D; Mazzola R; Morris SW; Saltman DL
    BMC Res Notes; 2015 Jul; 8():308. PubMed ID: 26187744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic Capability of Next-Generation Sequencing Fusion Analysis in Identifying a Rare CASE of
    Agarwal I; Sabatini L; Alikhan MB
    Front Oncol; 2020; 10():730. PubMed ID: 32457846
    [No Abstract]   [Full Text] [Related]  

  • 27. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
    Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features.
    Stein H; Foss HD; Dürkop H; Marafioti T; Delsol G; Pulford K; Pileri S; Falini B
    Blood; 2000 Dec; 96(12):3681-95. PubMed ID: 11090048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical, Histologic, and Molecular Characteristics of Anaplastic Lymphoma Kinase-positive Primary Cutaneous Anaplastic Large Cell Lymphoma.
    Melchers RC; Willemze R; van de Loo M; van Doorn R; Jansen PM; Cleven AHG; Solleveld N; Bekkenk MW; van Kester MS; Diercks GFH; Vermeer MH; Quint KD
    Am J Surg Pathol; 2020 Jun; 44(6):776-781. PubMed ID: 32412717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Anaplastic lymphoma kinase gene abnormality and the expression of its fusion protein in primary systemic anaplastic large cell lymphoma].
    Shi YF; Liu CL; Zhou CJ; Gong LP; Dong LN; Li M; Huang X; Gao ZF
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):380-6. PubMed ID: 18677384
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A small cell variant of ALK-positive, CD8-positive anaplastic large cell lymphoma with primary subcutaneous presentation mimicking subcutaneous panniculitis-like T-cell lymphoma.
    Wang E; Papalas J; Siddiqi I; Stoecker M; Rehder C; Sebastain S; Burchette J; Huang Q
    Pathol Res Pract; 2011 Aug; 207(8):522-6. PubMed ID: 21763080
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain metastasis of ALK positive anaplastic large cell lymphoma after a long-term disease free survival in an old adult.
    Wang CX; Wang H; Li J; Ma HH; Yu B; Shi SS; Zhou XJ; Shi QL
    Int J Clin Exp Pathol; 2014; 7(3):1182-7. PubMed ID: 24696735
    [TBL] [Abstract][Full Text] [Related]  

  • 33. How to Diagnose Anaplastic Large Cell Lymphoma on Cytological Samples? A Series with Emphasis on Diagnostic Clue and Pitfalls.
    Montella M; Lucà S; Ronchi A; Marino FZ; Caputo A; Sica A; Zeppa P; Franco R; Cozzolino I
    Acta Cytol; 2023; 67(3):230-239. PubMed ID: 36634640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping of genomic t(2;5)(p23;q35) break points in patients with anaplastic large cell lymphoma by sequencing long-range PCR products.
    Luthra R; Pugh WC; Waasdorp M; Morris W; Cabanillas F; Chan PK; Sarris AH
    Hematopathol Mol Hematol; 1998; 11(3-4):173-83. PubMed ID: 9844824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of the NPM-ALK genomic rearrangement of Ki-1 lymphoma and isolation of the involved NPM and ALK introns.
    Ladanyi M; Cavalchire G
    Diagn Mol Pathol; 1996 Sep; 5(3):154-8. PubMed ID: 8866227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements.
    Pittaluga S; Wlodarska I; Pulford K; Campo E; Morris SW; Van den Berghe H; De Wolf-Peeters C
    Am J Pathol; 1997 Aug; 151(2):343-51. PubMed ID: 9250148
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.
    Parrilla Castellar ER; Jaffe ES; Said JW; Swerdlow SH; Ketterling RP; Knudson RA; Sidhu JS; Hsi ED; Karikehalli S; Jiang L; Vasmatzis G; Gibson SE; Ondrejka S; Nicolae A; Grogg KL; Allmer C; Ristow KM; Wilson WH; Macon WR; Law ME; Cerhan JR; Habermann TM; Ansell SM; Dogan A; Maurer MJ; Feldman AL
    Blood; 2014 Aug; 124(9):1473-80. PubMed ID: 24894770
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The origins of ALK translocations.
    Roukos V; Mathas S
    Front Biosci (Schol Ed); 2015 Jun; 7(2):260-8. PubMed ID: 25961701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of t(2;5)(p23;q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis.
    Beylot-Barry M; Lamant L; Vergier B; de Muret A; Fraitag S; Delord B; Dubus P; Vaillant L; Delaunay M; MacGrogan G; Beylot C; de Mascarel A; Delsol G; Merlio JP
    Am J Pathol; 1996 Aug; 149(2):483-92. PubMed ID: 8701987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The use of fluorescent in situ hybridization for detection of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma.
    Johnson PW; Leek J; Swinbank K; Angus B; Roberts P; Markham AF; Selby PJ; MacLennan KA
    Ann Oncol; 1997; 8 Suppl 2():65-9. PubMed ID: 9209644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.